Skip to content

Treatment of acne

Mentha Piperitha essential oil versus clindamysine lotion 1% for treatment of acne vulguris: a randomized control clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102055759N1
Enrollment
80
Registered
2011-06-15
Start date
2011-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne. Disorders of skin appendages

Interventions

Intervention 1: clindamycine 1% solution two times a day for 6-8 weeks. Intervention 2: mentha piperta solution two times a day for 6-8 weeks.
Treatment - Drugs
clindamycine 1% solution two times a day for 6-8 weeks
mentha piperta solution two times a day for 6-8 weeks

Sponsors

Tabriz University of Medical Scinces
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients diagnosed with acne Exclusion criteria: Using Contraceptive,antibiotic ,sebum reducing product,steroidal agent,corticosteroid

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Persistance of acne. Timepoint: Each weekend for 6-8 weeks. Method of measurement: observation.;Severity of acne. Timepoint: Each week for 6-8 week. Method of measurement: TLC.;Severity of acne. Timepoint: Each week for 6-8 week. Method of measurement: ASI.

Secondary

MeasureTime frame
Irritation. Timepoint: Each week for 6- 8 weeks. Method of measurement: observation and physical examination.;Sensitivity. Timepoint: Each week for6-8 weeks. Method of measurement: Physical examination - Inspection.;Pain. Timepoint: Each week for 6- 8 weeks. Method of measurement: observation and physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Kamalifar

Tabriz University Of Medical Scinces

amirkamalifar@gmail.com \amirk_nba@yahoo.com+98 914 153 4548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026